Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 43
MetricValuePeriodScopeSource row
Revenue¥974m2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥3.0bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income−¥547m2025-04-01 → 2025-09-30Cons.Operating income
Operating income−¥149m2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income−¥483m2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥45m2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥103m2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax−¥483m2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax−¥103m2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)−¥486m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥103m2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥104m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income−¥486m2025-04-01 → 2025-09-30Cons.Profit loss
Net income−¥104m2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥9.4bnat 2025-09-30Cons.Assets
Total assets¥9.7bnat 2025-03-31Cons.Assets
Total assets¥9.4bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥688mat 2025-09-30Cons.Liabilities
Total liabilities¥686mat 2025-03-31Cons.Liabilities
Net assets / equity¥8.7bnat 2025-09-30Cons.Net assets
Net assets / equity¥9.0bnat 2025-03-31Cons.Net assets
Net assets / equity¥8.7bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥2.8bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥2.6bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow−¥342m2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥6m2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥131m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥123m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥796m2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥412m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥680m2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥681m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-5.142025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1.112024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.142024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio92.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio92.9%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.8%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2025-04-01 → 2025-09-30−¥341m
Medical Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥87m
Medical Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥87m
Medical Businessreportable segmentsegment ordinary income2025-04-01 → 2025-09-30−¥119m
Research Support Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥887m
Research Support Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥887m
Research Support Businessreportable segmentsegment ordinary income2025-04-01 → 2025-09-30−¥23m
—segment totalrevenue2025-04-01 → 2025-09-30¥974m
—segment totalrevenue external2025-04-01 → 2025-09-30¥974m
—segment totalsegment ordinary income2025-04-01 → 2025-09-30−¥142m
Reconciling Itemsreconcilingsegment ordinary income2024-04-01 → 2024-09-30−¥378m
Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥176m
Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥176m
Medical Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥8m
Research Support Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥1.1bn
Research Support Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.1bn
Research Support Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥267m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.3bn
—segment totalsegment ordinary income2024-04-01 → 2024-09-30¥275m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 470
ItemContextValueUnit
Selling general and administrative expensesPrior1InterimDuration855795000JPY
Selling general and administrative expensesInterimDuration933577000JPY
Operating incomePrior1InterimDuration-149176000JPY
Operating incomeInterimDuration-546630000JPY
Interest income noiPrior1InterimDuration31160000JPY
Interest income noiInterimDuration41493000JPY
Subsidy income noiPrior1InterimDuration14611000JPY
Subsidy income noiInterimDuration-JPY
Foreign exchange gains noiPrior1InterimDuration-JPY
Foreign exchange gains noiInterimDuration45008000JPY
Other noiPrior1InterimDuration11678000JPY
Other noiInterimDuration1185000JPY
Non operating incomePrior1InterimDuration57450000JPY
Non operating incomeInterimDuration87687000JPY
Equity in losses of affiliates noePrior1InterimDuration3735000JPY
Equity in losses of affiliates noeInterimDuration23470000JPY
Amortization of restricted stock compensation noePrior1InterimDuration4104000JPY
Amortization of restricted stock compensation noeInterimDuration-JPY
Foreign exchange losses noePrior1InterimDuration2937000JPY
Foreign exchange losses noeInterimDuration-JPY
Other noePrior1InterimDuration754000JPY
Other noeInterimDuration975000JPY
Non operating expensesPrior1InterimDuration11531000JPY
Non operating expensesInterimDuration24445000JPY
Ordinary incomePrior1InterimDuration-103257000JPY
Ordinary incomeInterimDuration-483389000JPY
Income before income taxesPrior1InterimDuration-103257000JPY
Income before income taxesInterimDuration-483389000JPY
Income taxes currentPrior1InterimDuration962000JPY
Income taxes currentInterimDuration2952000JPY
Income taxesPrior1InterimDuration962000JPY
Income taxesInterimDuration2952000JPY
Profit lossPrior1InterimDuration-104219000JPY
Profit lossInterimDuration-486341000JPY
Profit loss attributable to owners of parentPrior1InterimDuration-104219000JPY
Profit loss attributable to owners of parentInterimDuration-486341000JPY
Profit lossPrior1InterimDuration-104219000JPY
Profit lossInterimDuration-486341000JPY
Valuation difference on available for sale securities net of tax ociPrior1InterimDuration-82687000JPY
Valuation difference on available for sale securities net of tax ociInterimDuration163094000JPY
Foreign currency translation adjustment net of tax ociPrior1InterimDuration-27323000JPY
Foreign currency translation adjustment net of tax ociInterimDuration196000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1InterimDuration-35016000JPY
Share of other comprehensive income of associates accounted for using equity method ociInterimDuration13576000JPY
Other comprehensive incomePrior1InterimDuration-145027000JPY
Other comprehensive incomeInterimDuration176866000JPY
Comprehensive incomePrior1InterimDuration-249246000JPY
Comprehensive incomeInterimDuration-309474000JPY
Comprehensive income attributable to owners of the parentPrior1InterimDuration-249246000JPY
Comprehensive income attributable to owners of the parentInterimDuration-309474000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass